2nd Annual Pharma AI Summit

2nd Pharma AI summit

Decoding the Future Trajectory of Pharmaceutical Industry with Artificial Intelligence 

Zurich, Switzerland
October 15th–16th, 2020

Artificial Intelligence promises vast opportunities for economic and societal benefits in the pharmaceutical industry, lifesciences and healthcare including care delivery with digital health. As data applications supported by AI become more advanced, the whole healthcare value chain has been affected. New forms of drug discoveries and pharma workforces are going to evolve. At the same time, the collection of real-world evidence using AI platforms will alter the role of patients. Among these new technologies, it is important to follow up the developments and discoveries effecting pharmaceutical industry.

This conference provides a comprehensive view of the role that Artificial Intelligence plays, the key challenges and opportunities, as well as the strategic perspective on industry change. In times of disruptive innovation, success is based on a company’s ability to adapt, innovate and collaborate. This event therefore serves as a platform that fosters industry relationships, providing the opportunity for the development of innovative business solutions. We invite you to discuss and debate these challenges in a dialogue amongst top professionals in Pharma and Artificial Intelligence.

Key Practical Learning Points of the Summit:

  • How predictive models generated with AI could be effectively used in pharma?
  • How Artificial Intelligence helps to reach truly data-driven drug discovery?
  • How can advancements in AI and ML tools improve prediction of infectious disease outbreaks? What kinds of innovative public-private partnerships can be used to develop new AI tools? How does the pharma industry invest in the right AI solutions to deliver the right drug?
  • How Real World Evidence can make drug development cheap and more effective?
  • What is the best way to validate Clinical Trial Data with Artificial Intelligence?
  • What are the obstacles in the clinical trials for patients, physicians, IRB/HA, legal, Industry?
  • How AI can help in management, transmission and interpretation of imaging data?
  • How AI can help to interpret genomic variations and their effects on cellular responses? How AI is playing a role in managing medication safety at multiple levels?
  • How AI is used for knowledge sharing based on scope of collabrations and business models?

Who Should Attend:

Medical doctors | Research scientists | Data-scientists | CEOs| CTOs| Managers| Directors Department Heads |Biomedical |Research Engineers specializing  in pharmaceutical: 

  • Artificial Intelligence 
  • Machine-learning 
  • Drug discovery and development 
  • Data-science 
  • Deep-learning 
  • Predictive analytics 
  • Data-analytics 
  • Pre-clinical trials 
  • Clinical trials 
  • Clinical Data Management 
  • Medical imaging 
  • Bio-informatics 
  • Bio-technology 
  • Clinical innovation 
  • Scientific computing 
  • Drug design 
  • Risk Management 
  • Business Development 
  • Patient Support Programs 
  • Computational screening

Target Audience:

  • Pharmaceutical companies 
  • Healthcare Consultants 
  • Pharmacovigilance Consultants 
  • Healthcare Translation Agencies  
  • Biomedical companies 
  • Biotech companies 
  • CRO Service Providers 
  • AI and Machine-learning companies 
  • Data-analytics companies 
  • Technology Vendors 
  • Portal Service Providers 
  • Academicians

For any enquiry on regards to special offers & group discounts please contact us directly at:
info@globalbsg.com

Media Partners

The Medicine Maker celebrates the people, processes and vision that bring new drugs and biologics to market. The development and manufacture of new drugs and biological medicines draws on the talent, passion and experience of a wide range of professionals. The goal of The Medicine Maker is to bring this group into the limelight and, in doing so, to integrate the entire process, from the registration of an Investigational New Drug (IND) or Biologics License Application (BLA) through to the market launch of new therapies, and beyond.

Labiotech Insider’ is a membership program that helps biotech and biopharma leaders, investors, researchers and enthusiasts stay ahead with access to timely information about the European biotech ecosystem. Members also have exclusive access to events featuring biotech thought leaders and decision makers. Join the Insider community to support quality journalism and help Labiotech build a successful European biotech ecosystem! Benefit from a 30-day free subscription now.
Event Schedule
Event Speakers
Register
Individual Registration
€0
Start
Group Registration
€0
Start